A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer
-
Published:2024-06
Issue:3
Volume:2
Page:415-426
-
ISSN:2949-866X
-
Container-title:Intelligent Pharmacy
-
language:en
-
Short-container-title:Intelligent Pharmacy
Author:
Fatima Amreen,
Naseem Nazish,
Haider Md FaheemORCID,
Rahman Md Azizur,
Mall Jyotiraditya,
Saifi Muhammad Sahil,
Akhtar Juber
Reference113 articles.
1. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review;Memariani;Pharmacol Res,2021
2. Shared risk factors in cardiovascular disease and cancer;Koene;Circulation,2016
3. Adnan, M., Afzal, O., Altamimi, A.S., Alamri, M.A., Haider, T. and Haider, M.F., Development and optimization of Transethosomal gel of Apigenin for topical delivery: in-vitro, ex-vivo and cell line assessment. Int J Pharm, p.122506. 10.1016/j.ijpharm.2022.122506.
4. Exploring liposomes for lung cancer therapy;Shahid;Crit Rev Ther Drug Carrier Syst,2022
5. Screening and early detection of lung cancer;Eggert;InSeminars in oncology nursing,2017